The Nasdaq 100 enjoyed one of those well-timed Friday afternoon rallies (1.9% off morning trading lows) to somewhat ease ...

However, even in a market with generic competitors, Xywav offers a differentiated profile, and we will partner with payers to ...

Kubota, C. (2025) The Utility of Offering Course Subjects on Family Support for Paramedics in an Undergraduate Curriculum.

On track to submit GraftAssureDx™ for FDA review by year-endOn track for commitment to have 20 transplant centers globally ...

Record Quarterly Revenues of $708.0 Million, a 26% Increase from a Year Ago Quarterly Adjusted EBITDA (non-GAAP) Increased 39% from Prior Year Record Total Backlog and Awards of $3.1 Billion, 29% Incr ...

SAN JOSE, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Legence Corp. (Nasdaq: LGN) (“Legence” or the “Company”) today reported financial results for the third quarter ended September 30, 2025.

Worldwide Healthcare Trust PLC - Half-year Financial Report PR Newswire LONDON, United Kingdom, November 13 LONDON STOCK EXCHANGE ANNOUNCEMENT Worldwide ...